Davis's Drug Guide
beremagene geperpavec
General
Genetic Implications:
Pronunciation:
ber-em-a-jeen jep-er-pa-vek
Trade Name(s)
- Vyjuvek
Ther. Class.
wound/ulcer/decubiti healing agent
Pharm. Class.
temporary class
gene therapyThere's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Beremagene Geperpavec." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. www.drugguide.com/ddo/view/Davis-Drug-Guide/3580160/all/beremagene_geperpavec.
Vallerand AHA, Sanoski CAC. Beremagene geperpavec. Davis's Drug Guide. F.A. Davis Company; 2026. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/3580160/all/beremagene_geperpavec. Accessed August 31, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Beremagene geperpavec. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/3580160/all/beremagene_geperpavec
Vallerand AHA, Sanoski CAC. Beremagene Geperpavec [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 August 31]. Available from: https://www.drugguide.com/ddo/view/Davis-Drug-Guide/3580160/all/beremagene_geperpavec.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - beremagene geperpavec
ID - 3580160
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://www.drugguide.com/ddo/view/Davis-Drug-Guide/3580160/all/beremagene_geperpavec
PB - F.A. Davis Company
ET - 20
DB - Davis's Drug Guide
DP - Unbound Medicine
ER -